No AccessAmerican Journal of AudiologyClinical Focus: Grand Rounds1 Jun 1999

Conductive Hearing Loss in Individuals with Fibrodysplasia Ossificans Progressiva

    Fibrodysplasia ossificans progressiva (FOP) is a very rare genetic disorder that is characterized by progressive heterotopic ossification of soft tissues and congenital malformation of the great toes. Although previous case studies have reported hearing loss in individuals with FOP, there have been no large-scale studies regarding the nature or cause of the hearing loss. Here, we report the findings of a two-part study. In Part I, we report the findings of a postal survey regarding hearing loss that was sent to 102 individuals with FOP. In Part II, we report the findings of on-site hearing evaluations of eight individuals with FOP. The findings of both studies indicate that individuals with FOP are at risk for hearing loss and that the type of loss is predominantly conductive in nature, similar to that seen in individuals who have otosclerosis.


    • American National Standards Institute. (1991). Maximum permissible ambient noise for audiometric testing (ANSI No. S3.1-1991). New York: Author.
    • American Speech-Language-Hearing Association, Committee on Audiometric Evaluation. (1978). Guidelines for manual pure-tone threshold audiometry.Asha, 20, 297–301.
    • Carhart, R., & Jerger, J. F. (1959). Preferred method for clinical determination of pure-tone thresholds.Journal of Speech and Hearing Disorders, 24, 330–345.
    • Conner, J. M., & Beighton, P. (1982). Fibrodysplasia ossificans progressiva in South Africa: Case reports.South African Medical Journal, 61, 404–406.
    • Conner, J. M., & Evans, D. A. P. (1982). Genetic aspects of fibrodysplasia ossificans progressiva.Journal of Medical Genetics, 19, 35–39.
    • Delatycki, M., & Rogers, J. (1998). The genetics of fibrodysplasia ossificans progressiva.Clinical Orthopaedics and Related Research, 346, 15–18.
    • Jerger, J. (1970). Clinical experience with impedance audiometry.Archives of Otolaryngology, 92, 311.
    • Ludman, H., Hamilton, E. B. D., & Eade, A. W. T. (1968). Deafness in myositis ossificans progressiva.Journal of Laryngology and Otology, 82, 57–63.
    • Lutwak, L. (1964). Myositis ossificans progressiva.American Journal of Medicine, 37, 296.
    • Shafritz, A. B., Shore, E. M., Gannon, F. H., Zasloff, M. A., Taub, R. T., Muenke, M., & Kaplan, F. S. (1996). Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva.New England Journal of Medicine, 335, 555–592.
    • Sorensen, M. S. (1987). Fibrodysplasia ossificans progressiva and hearing loss.International Journal of Pediatric Otorhinolaryngology, 14, 79–82.
    • Terkildsen, K., Osterhannel, P., & Bretlau, P. (1973). Acoustic middle ear muscle reflexes in patients with otosclerosis.Archives of Otolaryngology, 98, 152–155.
    • Whyte, M. P., Kaplan, F. S., & Shore, E. (1996). Fibrodysplasia ossificans progressiva.In: M. J. Favus (Ed.), Primer on the metabolic bone diseases and disorders of mineral metabolism (3rd ed., pp. 428–430). Philadelphia, PA: Lippincott-Raven.

    Additional Resources